Updated: In new speed bump for Huntington's, FDA pauses PTC's PhII trial
PTC Therapeutics has run into a roadblock for its Huntington’s disease program as the FDA flashes the red light on a Phase II study. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.